Find a Clinical Trial anywhere…
Participating in a clinical trial is a great way to contribute to curing, preventing and treating liver disease and its complications. Start your search here to find clinical trials that need people like you.
NASH (Nonalcoholic Steatohepatitis)
Protocol
THIS TRIAL WILL BEGIN IN APRIL, 2021
Title
Phase 3 Semaglutide in NASH (ESSENCE)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Injectable medication for NASH
Notify
Malana Kanallakan
314- 328-6466
NASH (Nonalcoholic Steatohepatitis)
Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19
Title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (AURORA)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Oral medication for NASH
Notify
Malana Kanallakan
314- 328-6466
NASH (Nonalcoholic Steatohepatitis)
Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19
Title
A randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor (LJN452) & licogliflozin (LIK066) combination therapy, compared to each monotherapy, for treatment of adult patients with nonalcoholic steatohepatitis (NASH) (ELIVATE)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Oral medication for NASH
Notify
Malana Kanallakan
314- 328-6466
Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
University of Missouri Healthcare
The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver decompensation (AILD) through at least Study Day 91.
Contact Susan Pew, RN Study Coordinator for more information.
Phone: 573-882-4758
Email: pews@health.missouri.edu
